S. Melmed, U.B. Kaiser, M.B. Lopes, J. Bertherat, L.V. Syro, G. Raverot et al. Clinical biology of the pituitary adenoma. Endocr. Rev. 43(6), 1003–1037 (2022)

Article  PubMed  PubMed Central  Google Scholar 

N.A. Tritos, K.K. Miller, Diagnosis and management of pituitary adenomas. JAMA 329(16), 1386 (2023)

Article  CAS  PubMed  Google Scholar 

K. Ho, M. Fleseriu, U. Kaiser, R. Salvatori, T. Brue, M.B. Lopes et al. Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time? J. Endocr. Soc. 5(3), bvaa205 (2021)

Article  PubMed  PubMed Central  Google Scholar 

F. Ceccato, D. Regazzo, M. Barbot, L. Denaro, E. Emanuelli, D. Borsetto et al. Early recognition of aggressive pituitary adenomas: a single-centre experience. Acta Neurochir. 160(1), 49–55 (2018)

Article  PubMed  Google Scholar 

K.K.Y. Ho, M. Fleseriu, J. Wass, L. Katznelson, G. Raverot, A.S. Little et al. A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol. 12, 209–214 (2024)

Article  PubMed  PubMed Central  Google Scholar 

J. Trouillas, P. Roy, N. Sturm, E. Dantony, C. Cortet-Rudelli, G. Viennet et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 126(1), 123–135 (2013)

Article  PubMed  Google Scholar 

X.Y. Wan, J. Chen, J.W. Wang, Y.C. Liu, K. Shu, T. Lei, Overview of the 2022 WHO classification of pituitary adenomas/pituitary neuroendocrine tumors: clinical practices, controversies, and perspectives. Curr. Med. Sci. 42(6), 1111–1118 (2022)

Article  PubMed  Google Scholar 

A. Mondin, F. Ceccato PANOMEN-3 grading score is reliable in predicting pituitary adenoma behavior and prognosis: a single center cohort study, 2025, repository data of University of Padova, website: https://researchdata.cab.unipd.it/id/eprint/1343, https://doi.org/10.25430/researchdata.cab.unipd.it.00001343.

K.K.Y. Ho, U.B. Kaiser, P. Chanson, M. Gadelha, J. Wass, L. Nieman et al. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat. Rev. Endocrinol. 19(11), 671–678 (2023)

Article  PubMed  Google Scholar 

S. Petersenn, M. Fleseriu, F.F. Casanueva, A. Giustina, N. Biermasz, B.M.K. Biller et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat. Rev. Endocrinol. 19(12), 722–740 (2023)

Article  PubMed  Google Scholar 

M. Fleseriu, R. Auchus, I. Bancos, A. Ben-Shlomo, J. Bertherat, N.R. Biermasz et al. Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol. 9(12), 847–875 (2021)

Article  PubMed  PubMed Central  Google Scholar 

M. Fleseriu, B.M.K. Biller, P.U. Freda, M.R. Gadelha, A. Giustina, L. Katznelson et al. A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1), 1–13 (2021)

Article  PubMed  Google Scholar 

A. Mondin, F. Ceccato, G. Voltan, P. Mazzeo, R. Manara, L. Denaro et al. Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre. Pituitary 26, 551–560 (2023)

Article  PubMed  PubMed Central  Google Scholar 

F. Bioletto, M. Sibilla, V. Gasco, E. Ghigo, S. Grottoli, Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis. J. Endocrinol. Invest. 47, 2143–2155 (2024)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L.T. Braun, G. Rubinstein, S. Zopp, F. Vogel, C. Schmid-Tannwald, M.P. Escudero et al. Recurrence after pituitary surgery in adult Cushing’s disease: a systematic review on diagnosis and treatment. Endocrine 70(2), 218–231 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

F. Roelfsema, N.R. Biermasz, A.M. Pereira, Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1), 71–83 (2012)

Article  PubMed  Google Scholar 

M. Barbot, N. Albiger, S. Koutroumpi, F. Ceccato, A.C. Frigo, R. Manara et al. Predicting late recurrence in surgically treated patients with <scp>C</scp> ushing’s disease. Clin. Endocrinol. 79(3), 394–401 (2013)

Article  CAS  Google Scholar 

G. Vargas, B. Gonzalez, C. Ramirez, A. Ferreira, E. Espinosa, V. Mendoza et al. Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int. J. Endocrinol. 2015, 1–7 (2015)

Article  Google Scholar 

E.C. Coopmans, M.R. Postma, T.L.C. Wolters, S.W.F. van Meyel, R. Netea-Maier, A.P. van Beek et al. Predictors for remission after transsphenoidal surgery in acromegaly: a Dutch multicenter study. J. Clin. Endocrinol. Metab. 106(6), 1783–1792 (2021)

Article  PubMed  PubMed Central  Google Scholar 

N. Agrawal, A.G. Ioachimescu, Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review. Pituitary 23(5), 582–594 (2020)

Article  CAS  PubMed  Google Scholar 

A. Ferrés, L. Reyes, A. Di Somma, T. Topczewski, A. Mosteiro, G. Guizzardi et al. The prognostic-based approach in growth hormone-secreting pituitary neuroendocrine tumors (PitNET): tertiary reference center, single senior surgeon, and long-term follow-up. Cancers 15(1), 267 (2022)

Article  PubMed  PubMed Central  Google Scholar 

Y. Zou, D. Li, J. Gu, S. Chen, X. Wen, J. Dong et al. The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis. BMC Endocr. Disord. 21(1), 225 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

I.B. Andersen, M.G.R. Sørensen, S.C. Dogansen, K. Cheol Ryong, L. Vilar, U. Feldt‐Rasmussen et al. Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: a systematic review and meta‐analysis. Clin. Endocrinol. 97(5), 519–531 (2022)

Article  CAS  Google Scholar 

J. Lelotte, A. Mourin, E. Fomekong, A. Michotte, C. Raftopoulos, D. Maiter, Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients. Eur. J. Endocrinol. 178(3), 237–246 (2018)

Article  CAS  PubMed  Google Scholar 

S. Asioli, A. Righi, M. Iommi, C. Baldovini, F. Ambrosi, F. Guaraldi et al. Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur. J. Endocrinol. 180(2), 127–134 (2019)

Article  CAS  PubMed  Google Scholar 

J. Newell-Price, R. Pivonello, A. Tabarin, M. Fleseriu, P. Witek, M.R. Gadelha et al. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. Eur. J. Endocrinol. 182(2), 207–217 (2020)

Article  CAS  PubMed  Google Scholar 

M. Barbot, F. Ceccato, L. Lizzul, A. Daniele, M. Zilio, M.P. Gardiman et al. Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model. Neurosurg. Rev. 43(4), 1109–1116 (2020)

Article  CAS  PubMed  Google Scholar 

J. Honegger, F. Grimm, The experience with transsphenoidal surgery and its importance to outcomes. Pituitary 21(5), 545–555 (2018)

Article  PubMed  Google Scholar